AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · IEX Real-Time Price · USD
4.530
+0.040 (0.89%)
At close: Mar 28, 2024, 4:00 PM
4.608
+0.078 (1.72%)
After-hours: Mar 28, 2024, 7:08 PM EDT

AbCellera Biologics Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for AbCellera Biologics stock have an average target of 19, with a low estimate of 6.00 and a high estimate of 28. The average target predicts an increase of 319.43% from the current stock price of 4.53.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $6.00 $19 $20 $28
Change +32.45% +319.43% +341.50% +518.10%
* Price targets were last updated on Feb 21, 2024.

Analyst Ratings

The average analyst rating for ABCL stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Oct '23Nov '23Dec '23Jan '24Feb '24Mar '24
Strong Buy 332233
Buy 556653
Hold 000000
Sell 000000
Strong Sell 000000
Total 888886

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Benchmark
Benchmark
Strong Buy
Upgrades
n/a
Strong Buy Upgrades n/a n/a Feb 22, 2024
Stifel
Stifel
Strong Buy
Maintains
$21$17
Strong Buy Maintains $21$17 +275.28% Feb 21, 2024
Keybanc
Keybanc
Buy
Initiates
$6
Buy Initiates $6 +32.45% Dec 5, 2023
Piper Sandler
Piper Sandler
Buy
Initiates
$20
Buy Initiates $20 +341.50% Oct 13, 2023
Benchmark
Benchmark
Strong Buy
Maintains
$20$12
Strong Buy Maintains $20$12 +164.90% Aug 31, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
48.79M
from 38.03M
Increased by 28.30%
Revenue Next Year
69.79M
from 48.79M
Increased by 43.05%
EPS This Year
-0.60
from -0.51
EPS Next Year
-0.62
from -0.60
Year 2019202020212022202320242025202620272028
Revenue
11.61M233.16M375.20M485.42M38.03M48.79M69.79M83.01M135.97M182.55M
Revenue Growth
31.49%1,907.88%60.92%29.38%-92.17%28.30%43.05%18.94%63.81%34.26%
EPS
-0.010.450.480.50-0.51-0.60-0.62-0.75-0.210.09
EPS Growth
--6.67%4.17%------
No. Analysts -----1210633
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 81.3M 123.8M 159.3M 231.4M 335.0M
Avg 48.8M 69.8M 83.0M 136.0M 182.6M
Low 36.2M 45.5M 48.8M 70.6M 85.3M

Revenue Growth

Revenue Growth 20242025202620272028
High
113.9%
153.7%
128.2%
178.8%
146.4%
Avg
28.3%
43.1%
18.9%
63.8%
34.3%
Low
-4.9%
-6.8%
-30.1%
-15.0%
-37.3%

EPS Forecast

EPS 20242025202620272028
High -0.25 -0.14 -0.47 -0.22 0.09
Avg -0.60 -0.62 -0.75 -0.21 0.09
Low -0.99 -0.97 -0.99 -0.21 0.09

EPS Growth

EPS Growth 20242025202620272028
High - - - - -
Avg - - - - -
Low - - - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.